Cassava Sciences | PTIE - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 10.57B 171M 2025-12
Amgen USD 9.14B 432M 2026-03
Biogen USD 1.79B 76.6M 2026-03
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cassava Sciences USD 120K 697K 2025-12
Eisai JPY 249.06B 25B 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Geron USD 37.66M 1.71M 2025-09
J&J USD 21.33B 3.72B 2025-12
Merck USD 11.78B 345M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 16.17B 332M 2026-03
Roche Holding CHF 11.9B 460M 2025-12